• Sonuç bulunamadı

趨化激素及其受體在台灣異位性皮膚炎疾病中之角色探討

N/A
N/A
Protected

Academic year: 2021

Share "趨化激素及其受體在台灣異位性皮膚炎疾病中之角色探討"

Copied!
2
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

異位性皮膚炎是一種慢性反覆的發炎性皮膚疾病,病患通常搔癢難耐

,並且在特定部位有濕疹樣變化,患者個人或家族常有異位性體質 (At opy) 。 CC 趨化激素是具有促發炎能力的分子,在異位性皮膚炎與過 敏的病理機轉扮演重要角色。我們利用 ELISA 來檢測病人組與對照組 血漿中趨化激素的濃度,並使用流式細胞儀來測量週邊血液單核球上 趨化激素受體的表現量。實驗結果顯示病人組血漿中的免疫球蛋白 E

、 RANTES 、 MIP-1 與 Eotaxin 的濃度較對照組高。病人組血漿中的 MCP-1 較對照組低。趨化激素受器 CCR2 、 CCR3 與 CCR5 在兩組間 表現並無差異。此外, RANTES 啟動子區域的多型性對於 RANTES 的分泌量與異位性皮膚炎盛行率的影響已被廣泛討論,之前的研究顯 示在德國與匈牙利異位性皮膚炎病童中 RNATES 啟動子的多型性與疾 病有不同的相關性,因此我們利用聚合脢連鎖反應與直接定序法來分 析台灣地區異位性皮膚炎患者與對照組的 RANTES 啟動子區域的多型 性。結果顯示,兩者之間的多型性表現並無差異。綜合以上研究, Ig E 與 CC 趨化激素中的 RANTES 、 MIP-1 、 Eotaxin 在台灣地區異位 性皮膚炎患者體內的表現量確實有上升,而 RANTES 驅動子在 -28 與 -403 位置產生的多型性與異位性皮膚炎並無相關。

趨化激素及其受體在台灣異位性皮膚炎疾病中之 角色探討

(2)

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease characterized by extreme pruritus, typically distributed eczematous skin lesions and a personal or fam ily history of atopic diseases. CC chemokines are potent proinflammatory molecules wh ich play an important role in the pathophysiology of atopic dermatitis (AD) and allergy.

We determined the plasma level of C-C chemokines of AD and controls by ELISA and used flow cytometry to evaluate expression of chemokine receptors on peripheral blood mononuclear cells in both groups. Plasma levels of IgE, RANTES, MIP-1, and eotaxin were increased in severe AD patients, but not in moderate and mild AD compared with normal controls. MCP-1 level is lower in the patient group. Chemokine receptor CCR2, CCR3 and CCR5 were the same in both AD and control group. In addition, polymorphi sms in promoter region of RANTES have been found, which increase the expression of these chemokines and affect the prevalence of atopic dermatitis. Different studies showe d various roles of RANTES polymorphism in atopic dermatitis of German and Hungaria n children. We also investigated whether the presence of these polymorphisms was asso ciated with atopic dermatitis in Taiwan. Atopic dermatitis patients and controls were scr eened for genotype with a PCR and direct sequencing- based assay. No significant diffe rence in the frequency of the polymorphisms between atopic dermatitis patients and con trols was found. Our finding suggests augmented production of some CC-chemokine su ch as RANTES, MIP-1, and eotaxin but no MCP-1 correlates with clinical severity of at opic dermatitis. In Taiwan population, there was no association between the -28G and - 403A alleles polymorphism in the RANTES promoter and atopic dermatitis

Roles of chemokines and chemokine receptors among patients with atopic dermatitis in

Taiwan

Referanslar

Benzer Belgeler

(2) The expression of the KA receptor subunit GluR5/6/7 appeared as early as in the stem cell stage, decreased during differentiation, and increased toward neuronal maturation..

(2) The expression of the KA receptor subunit GluR 5/6/7 appeared as early as in the stem cell stage, decreased during differentiation, and increased tow ard neuronal maturation..

 肥胖是心血管疾病,腦中風,糖尿病及癌症的重要危險因子;高血壓、高血脂症、高膽固醇症、糖尿病及脂肪肝被認為是新陳代謝症候群(

會引發 glucocorticoidreceptor (GR)與 Stat3 在細胞核的交互作用,並且會引發 GR 接合在 GAP43-P2 promoter 上的 Stat3binding site,而 MP 亦 會使 GR 與 P53

STAT 信號路徑有關。我們進而發現,MP 會引發 glucocorticoidreceptor (GR)與 Stat3 在細胞核的交互作用,並且會引發 GR 接合在 GAP43-P2 promoter 上的 Stat3binding site,而 MP

Stat3binding site,而 MP 亦會使 GR 與 P53 結合,且會造成 P53 接合到 GAP43-P2 promoter 上的 P53binding site。在 NogoA 基因調控方 面,MP 會抑制 AMPA

我們進而發現,MP 會引發 glucocorticoidreceptor (GR)與 Stat3 在細胞核的交互作用,並且會引發 GR 接合在 GAP43-P2 promoter 上的 Stat3binding site,而 MP 亦會使 GR

 Ganoderma membrane in homogeneous conditions for wound healing and absortive rep aring of soft tissues was investigated as well as the structure of Ganoderma residues was